Evgen Pharma (GB:TCF) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
TheraCryf plc, a UK-based clinical stage drug development company specializing in oncology and neuropsychiatry, has issued over 2.27 million new ordinary shares to cover professional fees. This move brings the company’s total shares in issue to 429.6 million, offering potential investors an opportunity to engage with its promising pipeline of treatments. TheraCryf is listed on AIM in London under the ticker TCF.
For further insights into GB:TCF stock, check out TipRanks’ Stock Analysis page.
